You are viewing the site in preview mode
Skip to main content
| |
All individuals DP ≥ 5
|
Females DP ≥ 5
|
|---|
| |
All drugs
|
ATC G03 excluded
|
ATC J01 excluded
|
ATC N05 excluded
|
All drugs
|
ATC G03 excluded
|
|---|
|
Age
|
n = 2,227,152
|
2,131,961
|
1,997,440
|
2,111,966
|
1,356,934
|
1,262,497
|
|---|
|
0–9
|
6.6
|
6.6
|
3.6
|
6.5
|
5.7
|
5.7
|
|
10–19
|
6.2
|
5.2
|
4.3
|
5.9
|
8.3
|
6.4
|
|
20–29
|
9.9
|
8.3
|
7.5
|
9.1
|
15.2
|
11.8
|
|
30–39
|
13.9
|
12.5
|
11.2
|
12.8
|
19.7
|
16.7
|
|
40–49
|
18.4
|
17.4
|
15.9
|
16.8
|
23.8
|
21.8
|
|
50–59
|
30.2
|
28.9
|
27.4
|
28.3
|
36.3
|
33.5
|
|
60–69
|
42.3
|
41.1
|
39.4
|
40.4
|
46.8
|
44.4
|
|
70–79
|
62.4
|
61.6
|
60.0
|
60.2
|
65.5
|
64.1
|
|
80–89
|
75.1
|
74.7
|
73.2
|
72.7
|
77.3
|
76.7
|
|
90-
|
77.7
|
77.4
|
75.9
|
74.7
|
79.4
|
79.0
|
|
Total
|
24.4
|
23.4
|
21.9
|
23.2
|
29.6
|
27.5
|
- The prevalence (%) of DP ≥ 5 for all individuals and for females, with and without ATC G03, J01, and N05 in Sweden in 2006.
-
1 Sex hormones and modulators of the genital system
-
2 Antibacterials for systemic use
-
3 Psycholeptics
